Associations of Food and Nutrient Intakes with Serum IGF-I, IGF-II, IGFBP-3, TGF-β1, Total SOD Activity and sfas Levels among Middle-aged Japanese: The JACC Study

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue SUPPL.1, 2009, Pages 7-22

  Maruyama, Koutatsu ^a   Iso, Hiroyasu ^a,l   Ito, Yoshinori ^b   Watanabe, Yoshiyuki ^c   Inaba, Yutaka ^a,d   Tajima, Kazuo ^e   Nakachi, Kei ^f   Tamakoshi, Akiko ^g   Mori, Mitsuru ^h   Sakauchi, Fumio ^h   Motohashi, Yutaka ⁱ   Tsuji, Ichiro ^j   Nakamura, Yosikazu ^k   Mikami, Haruo ^m   Kurosawa, Michiko ⁿ   Hoshiyama, Yoshiharu ^o   Tanabe, Naohito ^p   Tamakoshi, Koji ^q   Wakai, Kenji ^b   Tokudome, Shinkan ^r   Hashimoto, Shuji ^s   Kikuchi, Shogo ^g   Wada, Yasuhiko ^t   Kawamura, Takashi ^u   Ozasa, Kotaro ^f   Miki, Tsuneharu ^v   Date, Chigusa ^f   Sakata, Kiyomi ^w   Kurozawa, Yoichi ^x   Yoshimura, Takesumi ^y   Fujino, Yoshihisa ^z   Shibata, Akira ^aa   Okamoto, Naoyuki ^ab   Shio, Hideo ^ac   more..

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d JISSEN WOMEN'S UNIVERSITY   (Japan)

^e AICHI CANCER CENTER HOSPITAL   (Japan)

^f RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^g AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^k JICHI MEDICAL UNIVERSITY   (Japan)

^l OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^m CHIBA CANCER CENTER   (Japan)

ⁿ JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^o UNIVERSITY OF HUMAN ARTS AND SCIENCES   (Japan)

^p NIIGATA UNIVERSITY   (Japan)

^q NAGOYA UNIVERSITY   (Japan)

^r NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^s FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^t KANSAI ROSAI HOSPITAL   (Japan)

^u KYOTO UNIVERSITY   (Japan)

^v NARA WOMEN'S UNIVERSITY   (Japan)

^w IWATE MEDICAL UNIVERSITY   (Japan)

^x TOTTORI UNIVERSITY   (Japan)

^y FUKUOKA INSTITUTE OF HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

^z UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^aa KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^ab KANAGAWA CANCER CENTER   (Japan)

^ac Moriyama Municipal Hospital   (Japan)

more..

Author keywords

Food and nutrient intake; IGF I II; IGFBP 3; sFAS Levels; Sod activity; TGF 1

Indexed keywords

BIOLOGICAL MARKER; COPPER ZINC SUPEROXIDE DISMUTASE; FAS ANTIGEN; FAS PROTEIN, HUMAN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SUPEROXIDE DISMUTASE; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIET; DIET SUPPLEMENTATION; FEMALE; HUMAN; JAPAN; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PROGNOSIS;

ADULT; AGED; ANTIGENS, CD95; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIET; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; JAPAN; MALE; MIDDLE AGED; PROGNOSIS; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77957340617     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Cadogan J, Eastell R, Jones N, Barker ME (1997). Milk intake and bone mineral acquisition in adolescent girls: randomised, controlled intervention trial. BMJ, 315, 1255-60.
2. Crowe FL, Key TJ, Allen NE, et al (2009). The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev, 18, 1333-40.
3. Date C, Fukui M, Yamamoto A, et al (2005). Reproducibility and validity of a self-administered food frequency questionnaire used in the JACC study. J Epidemiol, 15 Suppl 1, S9-23.
4. DeLellis K, Rinaldi S, Kaaks RJ, et al (2004). Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort. Cancer Epidemiol Biomarkers Prev, 13, 1444-51.
5. Devine A, Rosen C, Mohan S, Baylink D, Prince RL (1998). Effects of zinc and other nutritional factors on insulin-like growth factor I and insulin-like growth factor binding proteins in postmenopausal women. Am J Clin Nutr, 68, 200-6.
6. Gann PH, Kazer R, Chatterton R, et al (2005). Sequential, randomized trial of a low-fat, high-fiber diet and soy supplementation: effects on circulating IGF-I and its binding proteins in premenopausal women. Int J Cancer, 20, 116, 297-303.
7. Giovannucci E, Pollak M, Liu Y, et al (2003). Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men. Cancer Epidemiol Biomarkers Prev, 12, 84-9.
8. Gunnell D, Oliver SE, Peters TJ, et al (2003). Are diet-prostate cancer associations mediated by the IGF axis? A crosssectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men. Br J Cancer, 88, 1682-6.
9. Haldar S, Rowland IR, Barnett YA, et al (2007). Influence of habitual diet on antioxidant status: a study in a population of vegetarians and omnivores. Eur J Clin Nutr, 61, 1011-22.
10. Heaney RP, McCarron DA, Dawson-Hughes B, et al (1999). Dietary changes favorably affect bone remodeling in older adults. J Am Diet Assoc, 99, 1228-33.
11. Holmes MD, Pollak MN, Willett WC, Hankinson SE. (2002). Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev, 11, 852-61.
12. Ito Y, Nakachi K, Imai K, et al (2005). Stability of frozen serum levels of insulin-like growth factor-I, insulin-like growth factor-II, insulin-like growth factor binding protein-3, transforming growth factor beta, soluble Fas, and superoxide dismutase activity for the JACC study. J Epidemiol, 15 Suppl 1, S67-73.
13. Larsson SC, Wolk K, Brismar K, Wolk A (2005). Association of diet with serum insulin-like growth factor I in middle-aged and elderly men. Am J Clin Nutr, 81, 1163-7.
14. Lin Y, Tamakoshi A, Kikuchi S, et al (2004). Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death. Int J Cancer, 110, 584-8.
15. Lin Y, Kikuchi S, Tamakoshi A, et al (2006). Serum transforming growth factor-beta1 levels and pancreatic cancer risk: a nested case-control study (Japan). Cancer Causes Control, 17, 1077-82.
16. Lin Y, Nakachi K, Ito Y, et al (2009). Lack of association between serum transforming growth factor-beta 1 and cancer mortality risk in a nested case-control study in Japan. Asian Pac J Cancer Prev, 10, 273-278.
17. Manios Y, Moschonis G, Trovas G, Lyritis GP (2007). Changes in biochemical indexes of bone metabolism and bone mineral density after a 12-mo dietary intervention program: the Postmenopausal Health Study. Am J Clin Nutr, 86, 781-9.
18. McGreevy KM, Hoel BD, Lipsitz SR, Hoel DG (2007). Impact of nutrients on insulin-like growth factor-I, insulin-like growth factor binding protein-3 and their ratio in African American and white males. Public Health Nutr, 10, 97-105.
19. Norat T, Dossus L, Rinaldi S, et al (2007). Diet, serum insulinlike growth factor-I and IGF-binding protein-3 in European women. Eur J Clin Nutr, 61, 91-8.
20. Ohno Y, Tamakoshi A, for the JACC Study Group (2001). Japan Collaboraetive Cohort Study for evaluation of cancer risk sponsored by Monbusho. J Epidemiol, 11, 144-50.
21. Pham T-M, Fujino Y, Kikuchi S, et al (2007a). A nested casecontrol study of stomach cancer and serum insulin-like growth factor (IGF)-1, IGF-2 and IGF-binding protein (IGFBP)-3. Eur J Cancer, 43, 1611-6.
22. Pham T-M, Fujino Y, Kikuchi S, et al (2007b). A nested casecontrol study of stomach cancer incidence and serum superoxide dismutase activity in the Japan Collaborative Cohort study in Japan. Cancer Detect Prev, 31, 431-5.
23. Tamakoshi A, Yoshimura T, Inaba Y, et al (2005). Profile of the JACC Study. J Epidemiol, 15, S4-S8.
24. Tamakoshi A, Nakachi K, Ito Y, et al (2008). Soluble Fas level and cancer mortality: Findings from a nested case-control study within a large-scale prospective study. Int J Cancer, 123, 1913-6.
25. Wakai K, Ito Y, Suzuki K, et al (2002). Serum insulin-like growth factors, insulin-like growth factor-binding protein-3, and risk of lung cancer death: a case-control study nested in the Japan Collaborative Cohort (JACC) Study. Jpn J Cancer Res, 93, 1279-86.
26. Yatsuya H, Tamakoshi A, Tamakoshi K, et al (2005a). Lack of an association between serum level of transforming growth factor beta -1 and stomach cancer risk in the JACC study. Asian Pac J Cancer Prev, 6, 170-6.
27. Yatsuya H, Toyoshima H, Tamakoshi K, et al (2005b). Serum levels of insulin-like growth factor I, II, and binding protein 3, transforming growth factor beta-1, soluble fas ligand and superoxide dismutase activity in stomach cancer cases and their controls in the JACC Study. J Epidemiol, 15 Suppl 2, S120-5.